Delisted

Stopped trading. Last price we have: $33.27 on Apr 1, 2026. Fund positions aren't valued until we confirm what happened.

GLPGF

GALAPAGOS NV NPV ISIN BE0003818359 SEDOL B07Q2V5

GLPGF·B44170106·US·Common Stock·Healthcare - Biotechnology

GLPGF (GALAPAGOS NV NPV ISIN BE0003818359 SEDOL B07Q2V5) is held by 0 institutional investors as of Q3 2022.

0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold GLPGF.

Top Holders

Checking access…
Action
CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS
Exited
0(-100.0%)$1,0000.0%-20.91%
0
GLPGFGLPGFGALAPAGOS NV NPV ISIN BE0003818359 SEDOL B07Q2V5

Continue exploring

Smart money flow
Track where institutional capital is flowing
Discover new institutional entries
Fresh positions initiated this quarter
Check sector trends
Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYLLYEli Lilly & Co.
415 holders · $877.5B
UNHUNHUnitedHealth Group Inc.
415 holders · $299.1B
TMOTMOThermo Fisher Scientific Inc
400 holders · $151.4B
JNJJNJJohnson & Johnson
397 holders · $414.1B
DHRDHRDanaher Corporation
394 holders · $97.5B
ISRGISRGIntuitive Surgical Inc.
393 holders · $111.5B
MRKMRKMerck & Co., Inc
390 holders · $230.1B
ABBVABBVAbbVie Inc.
385 holders · $302.9B
BSXBSXBoston Scientific Corporation
385 holders · $51.8B
ABTABTAbbott Laboratories
382 holders · $113.8B
High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used